Extrait

This is a study to evaluate the safety and efficacy of IPX066 in advanced Parkinson's disease.

Critère d'inclusion

• Parkinson's disease

Pays

• Canada
• France
• Germany
• Poland
• Romania
• Spain
• Ukraine
• United States

Liens

• nct